BIO-key International (NASDAQ:BKYI) Stock Rating Lowered by Wall Street Zen

BIO-key International (NASDAQ:BKYI – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “sell” rating to a “strong sell” rating in a research report issued on Sunday, Wall Street Zen reports.

BKYI has been the subject of a number of other research reports. Zacks Research upgraded BIO-key International to a “hold” rating in a research note on Thursday, August 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a report on Thursday, October 15th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, BIO-key International has a consensus rating of “Reduce”.

View Our Latest Report on BKYI

BIO-key International Stock Performance

BKYI stock opened at $2.00 on Friday. The company has a market capitalization of $4.08 million, a price-to-earnings ratio of -0.30 and a beta of 0.52. BIO-key International has a fifty-two week low of $1.55 and a fifty-two week high of $8.95. The business’s 50 day moving average price is $2.39 and its two-hundred day moving average price is $4.27.

BIO-key International (NASDAQ:BKYI – Get Free Report) last posted its quarterly earnings results on Friday, November 13th. The technology company reported ($4.01) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($3.66). The company had revenue of $1.48 million for the quarter, compared to the consensus estimate of $2.40 million. BIO-key International had a negative net margin of 49.35% and a negative return on equity of 64.19%. Sell-side analysts forecast that BIO-key International will post -1.62 earnings per share for the current year.

BIO-key International Company Profile

(Get Free Report)

BIO-key International, Inc. develops biometric identity and access management technology. Its solutions help organizations verify users and manage access to applications, systems and data, with fingerprint recognition as a core capability. The company’s offerings include PortalGuard, an identity and access management platform with features such as multifactor authentication and single sign-on, as well as biometric software and fingerprint readers. BIO-key also provides identity-bound biometric authentication designed to link access to a person’s unique characteristics.

Featured Stories

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.